Clive Wilson Director and Chief Scientist Professor Clive Wilson's research has focused on the utilisation of imaging techniques in studying the behaviour of formulations in man. Together with colleagues at Queen's Medical Centre, Nottingham he was one of the pioneers in the application of scintigraphic imaging techniques in drug research, and has received the Amersham and Pfizer awards in recognition of this work.  His current areas of interest are split evenly between drug delivery to the eye and the transit: absorption relationship in oral drug formulation. He has supervised more than fifty Ph.D. students and has authored over 400 research papers, book chapters and reviews. The publications reflect his interest in imaging, physiology, physics, drug metabolism and pharmacokinetics.  He is on the editorial boards of the European Journal of Pharmaceutics & Biopharmaceutics, the AAPS Journal of Pharmaceutical Technology and the Controlled Release Society publications committee.  In addition to his role at Bio-Images, Professor Wilson is J P Todd Professor of Pharmaceutics at Strathclyde.  He is on the scientific advisory boards of six companies in the USA, India, Denmark and Israel and in 2005, received the GSK International Achievement award.  He was the Science chairman of the Royal Pharmaceutical Conference in 2007 and is currently a member of the steering committee of the EUFEPS Bioavailability & Biopharmaceutics group. Ian Stillie Financial Director Ian Stillie is a recognised serial entrepreneur, who has been involved in 14 start-up companies, 5 acquisitions and 6 company disposals, as well as advising in several major disposals and turnaround situations. He has gained strong financial structuring and sales skills through experience of ventures in a range of disciplines, including biotechnology, engineering, mining, software and the media. Ian was educated at the University of Strathclyde, where he obtained a BSc (hons) in Mining and Petroleum Engineering. He then obtained a Graduate Diploma in Engineering from the University of the Witwatersrand, South Africa before returning to Strathclyde to complete a Masters in Business Administration. He is a Member of the Institute of Energy, a Fellow of the Chartered Institute of Marketing, holds a Diploma of the Chartered Institute of Marketing and is a Fellow of the Royal Society of the Arts. His current interests include turnarounds and investment in process-driven businesses and start-ups. Ken Downie Business Development Director Ken Downie has enjoyed a 30 year career in the Pharmaceutical, Biotec and Drug Delivery industries. Working with mid/large sized Pharma companies, both in the UK and in International positions, he has gained a broad experience in sales, marketing and International strategy. In the last 11 years, working at Business Development Director level, he has operated with a global remit for Biotec and Drug Delivery companies, concluding multiple product development and licensing deals in Europe, US and Japan. Ken has a degree in Applied Biology from Glasgow Caledonian University and a Marketing qualification from the Chartered Institute of Marketing.